Program & Downloads
Click here to download the program
Read articles from Liver International
Click here to view the speakers list
CONGRESS 2014
- 08:30 Introduction: Treatment of hepatitis C: soon the end of the road ? - Patrick MARCELLIN (France) Download
-
08:45 - 09:15
State of the art lecture and Award
Chairman:
Tarik ASSELAH (France)
- 08:45 ANRS: perspectives for basic research in viral hepatitis - Jean-François DELFRAISSY (France) Download
-
09:15 - 10:30
How to optimize current therapy of G1 patients
Chairs :
Ira JACOBSON (USA) Masao OMATA (Japan)
- 09:15 Personalized treatment with telaprevir - Graham FOSTER (UK) Download
- 09:30 Personalized treatment with boceprevir - Marc BOURLIERE (France) Download
- 09:45 Is there still a role for PEG IFN+RBV therapy? - Lawrence SERFATY (France) Download
- 10:00 Round table discussion
- 10:30 - 11:00 Coffee break
-
11:00 - 12:00
How to optimize current therapy of non G1 patients
Chairs :
Graham FOSTER (UK) Michael MANNS (Germany)
- 11:00 Genotype 2 - Adrian GADANO (Argentina) Download
- 11:15 Genotype 3 - Stanislas POL (France) Download
- 11:30 Genotype 4 - Tarik ASSELAH (France) Download
- 11:45 Round table discussion
-
12:00 - 12:30
State of the art lecture and Award
Chairman:
Patrick MARCELLIN (France)
- 12:00 Milestones in viral hepatitis - Christian TREPO (France) Download
-
12:30 - 14:30 Interactive luncheons Room 1
The long term impact of treatment on the outcome of liver disease?
Chairs: Michael FRIED (USA) Stefan ZEUZEM (Germany)
Room 2
First line therapy: interferon or analogues?
Chairs: Massimo COLOMBO (Italy) Teerha PIRATVISUTH (Thailand)
Room 3
Clinical applications of HBsAg quantification
Chairs: Henry CHAN (Hong Kong) Maurizia BRUNETTO (Italy)
Room 4
Staging of fibrosis: liver biopsy or indirect markers?
Chairs: Sam LEE (Canada) Victor DE LEDINGHEN (France)
Room 5
Treatment of HCV cirrhosis and transplanted patients
Chairs: Didier SAMUEL (France) Dominique VALLA (France)
Room 7
Interféron ou analogue ? (French speaking luncheon)
Chairs: Jean-Pierre ZARSKI (France) Philippe SOGNI (France)
Room 8
Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon)
Chairs: Nathalie BOYER (France) Download Jean-François David CADRANEL (France) Download Mustapha BENAZZOUZ (Morocco) Download
-
14:30 -15:45
Special populations
Chairs :
Sam LEE (Canada) François DURAND (France)
- 14:30 Patients with cirrhosis - Savino BRUNO (Italy) Download
- 14:45 Transplant patients - Didier SAMUEL (France) Download
- 15:00 HIV co-infected patients - Douglas DIETERICH (USA) Download
- 15:15 Round table discussion
- 15:45 - 16:00 Coffee break
-
16:00 - 17:15
New therapeutic strategies
Chairs :
David NELSON (USA) Stefan ZEUZEM (Germany)
- 16:00 Advantages of 2nd generation triple therapy - Tarik ASSELAH (France) Download
- 16:15 Protease, polymerase and NS5A inhibitors: what will be the wining combination? - Raymond SCHINAZI (USA) Download
- 16:30 Do we still need ribavirin? - Mark SULKOWSKI (USA) Download
- 16:45 Round table discussion
-
17:15
Controversy: F1/F2 patients: treat or wait?
Chairs :
Eugene SCHIFF (USA) Robert FLISIAK (Poland)
- 17:15 Treat now - Yves BENHAMOU (France) Download
- 17:30 Still wait - Mitchell SHIFFMAN (USA) Download
- 17:45 Conclusion - Patrick MARCELLIN (France)
- 18:00 Ajournement
- 19:30 Congress dinner
-
08:30
Introduction: HBV: Who, when and how to treat?
Chairman:
Patrick MARCELLIN (France) Download
-
08:40 - 10:00
The control of HBV related liver disease
Chairs :
Henry CHAN (Hong Kong) Fabien ZOULIM (France)
- 08:40 Regression of fibrosis. Is cirrhosis reversible? - Antonio CRAXI (Italy) Download
- 08:55 Are non-invasive markers of fibrosis reliable? - Laurent CASTERA (France) Download
- 09:10 HBsAg quantitation : useful for staging the liver disease? - Maurizia BRUNETTO (Italy) Download
- 09:25 HBsAg quantitation : useful for the indication and follow-up of therapy ? - Michelle MARTINOT-PEIGNOUX (France) Download
- 09:40 Round table discussion
- 10:00 - 10:30 Coffee break
-
10:30 - 11:30
Optimal therapy of HBeAg-positive chronic hepatitis B
Chairs :
Jidong JIA (China) Michael FRIED (USA)
- 10:30 Why do I treat my patient with a NUC? - Maria BUTI (Spain) Download
- 10:45 Why do I treat my patient with pegylated IFN? - Jia-Horng KAO (Taiwan) Download
- 11:00 Round table discussion
-
11:30 - 12:30
Optimal therapy of HBeAg-negative chronic hepatitis B
Chairs :
Seng Gee LIM (Singapore) Feruccio BONINO (Italy)
- 11:30 Why do I treat my patient with a NUC? - Pietro LAMPERTICO (Italy) Download
- 11:45 Why do I treat my patient with pegylated IFN? - Georgios PAPATHEODORIDIS (Greece) Download
- 12:00 Round table discussion
-
12:30 - 14:30 Interactive luncheons Room 1
How to optimize treatment in G1 naive patients?
Chairs: Antonio CRAXI (Italy) Vlad RATZIU (France)
Room 2
Resistance to DAAs: is this a real issue?
Chairs: Raymond SCHINAZI (USA) Philippe MATHURIN (France)
Room 3
How to manage relapsers and non-responders to PEG IFN + RBV therapy?
Chairs: Peter FERENCI (Austria) Download Andrzej HORBAN (Poland) Konstantin ZHDANOV (Russia)
Room 4
Triple therapy with telaprevir or boceprevir: management of side effects
Chairs: Rafael ESTEBAN (Spain) Markus PECK RADOSAVLJEVIC (Austria)
Room 5
Future therapeutic strategies with direct acting antivirals
Chairs: Yves BENHAMOU (France) Massimo LEVRERO (France)
Room 7
Traitement des patients rechuteurs et non-répondeurs (French speaking luncheon)
Chairs: Christophe HEZODE (France) Jean-Pierre BRONOWICKI (France)
Room 8
Comment optimiser le traitement des malades naïfs ? (French speaking luncheon)
Chairs: Daniel DHUMEAUX (France) Mihai VOICULESCU (Romania) Download
-
14:30 - 16:30
New therapeutic perspectives
Chairs :
Mario RIZZETTO (Italy) George LAU (Hong Kong)
- 14:30 New interferons and immunomodulators - Jake LIANG (USA) Download
- 14:45 Impact of HBV therapy on the incidence of hepatocellular carcinoma - Massimo COLOMBO (Italy) Download
- 15:00 When to stop NUCs? - Rafael ESTEBAN (Spain) Download
- 15:15 Round table discussion
- 15:45 Conclusion: tomorrow and after tomorrow? - Patrick MARCELLIN (France) Download
- 16:00 Ajournement